Profile data is unavailable for this security.
About the company
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.
- Revenue in USD (TTM)3.37bn
- Net income in USD-198.60m
- Incorporated1990
- Employees6.48k
- LocationHologic Inc250 Campus DrMARLBOROUGH 01752-3020United StatesUSA
- Phone+1 (508) 263-2900
- Fax+1 (302) 655-5049
- Websitehttps://www.hologic.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABIOMED, Inc. | 820.28m | 220.82m | 8.26bn | 1.37k | 38.21 | 8.35 | 34.77 | 10.07 | 4.79 | 4.79 | 17.80 | 21.92 | 0.8156 | 1.83 | 9.74 | 598,310.80 | 21.96 | 21.86 | 24.30 | 24.64 | 82.83 | 83.57 | 26.92 | 25.19 | 4.96 | -- | 0.00 | 0.00 | 29.59 | 33.18 | 93.92 | 103.89 | 73.97 | -- |
| Masimo Corporation | 913.46m | 191.13m | 9.06bn | 1.50k | 49.88 | 8.18 | 42.33 | 9.92 | 3.39 | 3.37 | 16.19 | 20.67 | 0.758 | 2.99 | 7.89 | 608,972.70 | 15.86 | 23.42 | 18.06 | 29.24 | 66.84 | 66.40 | 20.92 | 24.15 | 5.50 | -- | 0.00 | 0.00 | 8.61 | 9.42 | -4.12 | 27.20 | 11.75 | -- |
| Henry Schein, Inc. | 10.69bn | 491.38m | 10.45bn | 18.00k | 21.80 | 3.68 | 15.30 | 0.9772 | 3.27 | 3.31 | 71.04 | 19.35 | 1.38 | 4.56 | 7.36 | 594,003.60 | 6.38 | 7.78 | 11.35 | 13.60 | 29.84 | 27.71 | 4.62 | 4.59 | 0.9215 | 16.95 | 0.2254 | 0.00 | 5.94 | 6.67 | -7.53 | 3.37 | 8.52 | -- |
| West Pharmaceutical Services Inc. | 1.79bn | 227.00m | 11.52bn | 7.70k | 51.67 | 7.75 | 35.63 | 6.43 | 3.01 | 3.05 | 23.79 | 20.10 | 0.8698 | 5.52 | 5.79 | 232,701.30 | 10.68 | 8.75 | 12.58 | 10.34 | 32.69 | 32.21 | 12.28 | 10.03 | 2.31 | 53.00 | 0.1159 | 22.76 | 7.40 | 4.65 | -12.12 | 12.73 | -7.64 | 8.16 |
| Insulet Corporation | 693.71m | 16.53m | 11.90bn | 1.17k | 757.48 | 79.02 | 299.85 | 17.16 | 0.2542 | 0.2542 | 10.98 | 2.44 | 0.6439 | 3.20 | 8.81 | 593,424.30 | 1.53 | -6.52 | 1.70 | -7.53 | 65.81 | 59.20 | 2.38 | -8.47 | 6.21 | 1.58 | 0.8675 | -- | 21.57 | 17.94 | 112.41 | -- | 85.93 | -- |
| Steris PLC | 2.90bn | 335.96m | 12.83bn | 12.00k | 38.52 | 3.97 | 22.63 | 4.43 | 3.93 | 3.93 | 33.88 | 38.08 | 0.5679 | 7.06 | 5.77 | 241,507.80 | 6.61 | 4.44 | 7.18 | 4.88 | 43.00 | 41.01 | 11.64 | 7.73 | 1.86 | 11.19 | 0.2683 | 45.86 | 6.19 | 11.39 | 11.78 | 18.62 | 17.04 | 10.16 |
| DENTSPLY SIRONA Inc | 3.98bn | 160.70m | 13.27bn | 16.40k | 83.57 | 2.62 | 27.49 | 3.34 | 0.7139 | 0.7215 | 17.71 | 22.75 | 0.4642 | 2.97 | 5.68 | 242,524.40 | 1.87 | -4.06 | 2.11 | -4.52 | 52.28 | 54.12 | 4.03 | -8.88 | 1.39 | 162.96 | 0.2186 | -- | -0.1778 | 6.20 | 33.65 | -- | 13.14 | 7.61 |
| Varian Medical Systems, Inc. | 3.23bn | 298.10m | 13.48bn | 10.06k | 45.73 | 7.61 | 34.44 | 4.18 | 3.24 | 3.18 | 35.09 | 19.47 | 0.877 | 3.75 | 3.05 | 320,522.80 | 8.11 | 8.58 | 14.50 | 15.00 | 42.49 | 42.57 | 9.25 | 10.95 | 0.9787 | -- | 0.1874 | 0.00 | 10.48 | 1.12 | -16.66 | -5.88 | -8.34 | -- |
| Hologic, Inc. | 3.37bn | -198.60m | 14.19bn | 6.48k | -- | 6.80 | 53.62 | 4.21 | -0.7447 | -0.763 | 12.46 | 7.90 | 0.4926 | 3.90 | 5.48 | 519,820.90 | -2.91 | 1.49 | -3.55 | 1.78 | 51.95 | 53.11 | -5.90 | 3.70 | 1.26 | 4.47 | 0.5925 | 0.00 | 4.64 | 5.88 | 56.59 | -- | 7.21 | -- |
| Cooper Companies Inc | 2.65bn | 460.90m | 17.29bn | 12.00k | 38.11 | 4.77 | 23.31 | 6.52 | 9.25 | 9.36 | 53.23 | 73.90 | 0.4284 | 1.84 | 6.55 | 221,116.70 | 7.44 | 6.60 | 8.58 | 7.44 | 66.21 | 63.11 | 17.37 | 15.05 | 0.5911 | 7.52 | 0.3348 | 0.8777 | 4.76 | 9.09 | 30.01 | 11.30 | 4.18 | 0.00 |
| Teleflex Incorporated | 2.56bn | 441.69m | 17.59bn | 15.20k | 40.49 | 6.16 | 26.86 | 6.88 | 9.39 | 9.43 | 54.38 | 61.65 | 0.4104 | 2.48 | 6.63 | 168,159.50 | 7.09 | 4.87 | 7.76 | 5.55 | 57.09 | 53.79 | 17.28 | 11.13 | 1.44 | 5.15 | 0.412 | 26.28 | 14.07 | 7.62 | -25.36 | 5.36 | 4.91 | 0.00 |
| Align Technology, Inc. | 2.29bn | 418.91m | 21.28bn | 11.66k | 51.86 | 16.30 | 42.36 | 9.29 | 5.21 | 5.21 | 28.47 | 16.57 | 1.07 | 8.85 | 4.81 | 196,486.20 | 20.03 | 17.86 | 30.71 | 24.15 | 72.24 | 75.06 | 18.70 | 19.73 | 1.62 | -- | 0.00 | 0.00 | 33.47 | 24.39 | 26.77 | 44.15 | 62.99 | -- |
Data as of Jan 24 2020. Currency figures normalised to Hologic Inc's reporting currency: US Dollar USD
58.61%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 2019 | 42.17m | 15.73% |
| The Vanguard Group, Inc.as of 30 Sep 2019 | 29.86m | 11.13% |
| Parnassus Investmentsas of 30 Sep 2019 | 15.83m | 5.90% |
| BlackRock Fund Advisorsas of 30 Sep 2019 | 14.60m | 5.44% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2019 | 12.72m | 4.74% |
| SSgA Funds Management, Inc.as of 30 Sep 2019 | 11.21m | 4.18% |
| Capital Research & Management Co. (World Investors)as of 30 Sep 2019 | 10.73m | 4.00% |
| Glenview Capital Management LLCas of 30 Sep 2019 | 8.21m | 3.06% |
| Wellington Management Co. LLPas of 30 Sep 2019 | 7.09m | 2.65% |
| Geode Capital Management LLCas of 30 Sep 2019 | 4.76m | 1.78% |
More ▼
Data from 30 Sep 2019 - 30 Sep 2019Source: FactSet Research Systems Inc.
